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Protein ubiquitination plays an important role in the regulation of many cellular processes, including pro-
tein degradation, cell cycle regulation, apoptosis, and DNA repair. To study the ubiquitin proteome we
have established an immunoafﬁnity puriﬁcation method for the proteomic analysis of endogenously
ubiquitinated protein complexes. A strong, speciﬁc enrichment of ubiquitinated factors was achieved
using the FK2 antibody bound to protein G-beaded agarose, which recognizes monoubiquitinated and
polyubiquitinated conjugates. Mass spectrometric analysis of two FK2 immunoprecipitations (IPs)
resulted in the identiﬁcation of 296 FK2-speciﬁc proteins in both experiments. The isolation of ubiquiti-
nated and ubiquitination-related proteins was conﬁrmed by pathway analyses (using Ingenuity Pathway
Analysis and Gene Ontology-annotation enrichment). Additionally, comparing the proteins that speciﬁ-
cally came down in the FK2 IP with databases of ubiquitinated proteins showed that a high percentage
of proteins in our enriched fraction was indeed ubiquitinated. Finally, assessment of protein–protein
interactions revealed that signiﬁcantly more FK2-speciﬁc proteins were residing in protein complexes
than in random protein sets. This method, which is capable of isolating both endogenously ubiquitinated
proteins and their interacting proteins, can be widely used for unraveling ubiquitin-mediated protein
regulation in various cell systems and tissues when comparing different cellular states.
 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-SA license. The regulation of proteins involves posttranslational modiﬁca-
tions (PTMs)—such as phosphorylation and ubiquitination—to
control their activity, localization, stability, and assembly into
protein complexes. Ubiquitination was shown to play an increas-
ingly important role in many cellular processes, including protein
degradation, cell-cycle regulation, apoptosis, and DNA repair [1–
4]. The highly conserved 76-amino-acid protein ubiquitin can be
covalently attached to a lysine residue in protein substrates via
an E1–E2–E3 enzymatic cascade. The E1-activating enzyme uses
an ATP molecule to form a high-energy thioester bond between
the C-terminus of ubiquitin and an internal cysteine residue.
Next, the activated ubiquitin is transferred to a ubiquitin-conju-
gating enzyme (E2). Finally, an E3 ubiquitin ligase is needed to
transfer the ubiquitin to a lysine on the protein substrate [5]. Fol-
lowing addition of a single ubiquitin to a protein substrate(monoubiquitination), further ubiquitin molecules can be conju-
gated to the ﬁrst, resulting in a ubiquitin chain (polyubiquitina-
tion). Distinct chain linkages can be formed at all seven internal
lysine residues of ubiquitin (K6, K11, K27, K29, K33, K48, and
K63) and at its N-terminus (M1). Next to homotypic ubiquitin
chains, which have a single linkage type, heterotypic chains exist
containing mixed linkages within the same ubiquitin chain. The
most abundant chain linkage, through K48, is primarily a signal
for proteasomal degradation, while linkage through K63 has a
well-established role in cell signaling. In comparison, relatively
little is known about the other chain-linkage types [6,7]. The
ubiquitination process is highly dynamic and reversible, as illus-
trated by the existence of at least 80 different deubiquitinating
enzymes (DUBs), which can remove ubiquitin moieties from pro-
tein substrates [8–11].
The ubiquitination status of speciﬁc proteins can be studied by
immunoblotting. To study the ubiquitin proteome, also known as
the ubiquitinome, on a global scale, mass spectrometry (MS)-based
proteomics is used. Since presumably not all proteins are ubiquiti-
nated and as from those that are ubiquitinated only a fraction is
usually modiﬁed at a given time, methods to enrich for these pro-
teins are necessary to study them by MS [12].
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were primarily based on the ectopic overexpression of tagged
ubiquitin combined with a puriﬁcation protocol incorporating at
least one denaturing step to remove nonubiquitinated interactors
[13–22]. Despite its proven use, it cannot be excluded that exoge-
nous overexpression of tagged ubiquitin may lead to biased incor-
poration into monoubiquitination or certain ubiquitin chains and/
or may interfere with, e.g., the stability, activity, and localization of
ubiquitinated proteins. Additionally, tagged ubiquitin is not easily
introduced into tissues and cell types that are difﬁcult to transfect,
such as primary and quiescent cells, limiting its applicability.
Alternatively, some studies have made use of ubiquitin-binding
domains (UBDs) or anti-ubiquitin antibodies to isolate endoge-
nously ubiquitinated proteins [13,23–30] or peptides [31–35],
thereby overcoming the above-mentioned limitations.
Proteolytic digestion of ubiquitinated proteins with trypsin
generates a speciﬁc diglycine (Gly–Gly) remnant on the e amino
group of the ubiquitinated lysine. This remnant causes a distinct
mass shift of the peptide mass that can be used to precisely iden-
tify and localize the site of ubiquitination in the peptide. The recent
development of speciﬁc antibodies directed against diglycine-
modiﬁed peptides enables the efﬁcient isolation of these peptides
and the identiﬁcation of ubiquitination sites by MS [31–35]. Be-
cause of the denaturing step that is necessary before trypsin diges-
tion, the identiﬁcation of nonubiquitinated interactors using this
approach is minimal.
Most of the methods for endogenously ubiquitinated protein
isolation were performed under nondenaturing conditions, which
are necessary for efﬁcient binding of the UBDs or antibodies to
the ubiquitinated proteins. Although the ubiquitinated protein
pool might be exposed to residual DUB and proteasome activity
under these conditions, it has the additional advantage of allowing
the study of protein complexes. Most biological processes mainly
rely on intact, functional protein complexes [36], whose subunits,
however, are not necessarily all modiﬁed by ubiquitin. Therefore,
to study the biologically relevant protein modules, including the
nonubiquitinated interactors, we started out by comparing three
different methods for the isolation of endogenously ubiquitinated
protein complexes under nondenaturing conditions. The most efﬁ-
cient approach of the three, a method based on FK2 antibody
immunoprecipitation (IP), was further optimized and character-
ized for proteomic applications.Methods
Cell culture
HeLa and XP2OS cells were cultured in Dulbecco’s modiﬁed Ea-
gle’s medium (Invitrogen) supplemented with 10% fetal calf serum,
50 units/ml penicillin, and 50 lg/ml streptomycin (Gibco) at 37 C
and 5% CO2 in a humidiﬁed cell culture incubator. Cells were grown
to 90% conﬂuence in 9-cm dishes for all experiments.Isolation of endogenously ubiquitinated protein complexes
Cells were washed twice in ice-cold phosphate-buffered saline
(PBS) and harvested by scraping in 500 ll lysis buffer. Either RIPA
lysis buffer (PBS containing 1% Nonidet P-40, 0.5% sodium deoxy-
cholate, 0.1% SDS) or tandem ubiquitin-binding entities (TUBEs) ly-
sis buffer (50 mM Tris–HCl, pH 7.5, 0.15 M NaCl, 1 mM EDTA, 1%
NP-40, 10% glycerol) was used, both supplemented with 15 lM
MG-132 (Enzo Life Sciences), 10 mM N-ethylmaleimide (Sigma),
and Complete protease inhibitor cocktail (Roche). Lysates were
incubated on ice for 10 min and centrifuged at 16,000g and 4 C
for 15 min to remove remaining cell debris and DNA. Clearedlysates were added to the various puriﬁcation resins: 100 ll 50%
slurry of agarose–TUBEs (LifeSensors), UbiQapture-Q matrix (Enzo
Life Sciences), FK2 beads, or control beads. The FK2 beads and
control beads were prepared by incubating 100 ll 50% protein
G-beaded agarose slurry (Pierce) with 87.5 lg of FK2 antibody
(Enzo Life Sciences) or random mouse IgG (Millipore) for 40 min
at room temperature. For cross-linking FK2 to the protein G beads
the Pierce Crosslink Immunoprecipitation Kit was used. All resins
were washed two times with lysis buffer before use. After incubat-
ing with lysates for 4 or 16 h at 4 C, the nonbound fractions were
collected and the resins were washed four times with 10 bead vol-
umes of lysis buffer. Bound protein complexes were eluted in 1
bead volume of 2 Laemmli buffer for 5 min at 98 C and loaded
onto a 4–20% SDS–PAGE precast gradient gel (Invitrogen).
Three different elution buffers compatible with a concentration
step using centrifugal ﬁlters (Amicon Ultra; Millipore) were tested
for releasing ubiquitinated protein complexes from the FK2 beads:
8 M urea buffer (8 M urea, 300 mM NaCl, 50 mM Na2HPO4, 0.5%
NP-40; pH 8), 2% SDS, or 0.1 M glycine, pH 2. Proteins were eluted
in four consecutive steps by shaking for 5 min at 1250 rpm in an
Eppendorf Thermomixer in 2 bead volumes of elution buffer.Mass spectrometric analysis
Endogenously ubiquitinated protein complexes were isolated
from one 90% conﬂuent 9-cm dish of HeLa cells for each experi-
ment using the FK2 beads as described above. SDS–PAGE gel lanes
were cut into 2-mm slices using an automatic gel slicer and sub-
jected to in-gel reduction with dithiothreitol. Protein alkylation
with iodoacetamide can produce a 2-acetamidoacetamide covalent
adduct to lysine residues, which has an atomic composition and
mass identical to that of the diglycine remnant present at ubiqui-
tinated lysines after trypsin digestion [37]. To prevent false-posi-
tive identiﬁcation of ubiquitinated peptides we used deuterium-
labeled iodoacetamide (98%; D4; Cambridge Isotope Laboratories)
for alkylation. Proteins were subsequently digested with trypsin
(Promega; sequencing grade), as described previously [38]. Nano-
ﬂow liquid chromatography–tandem mass spectrometry (LC–MS/
MS) was performed on an 1100 Series capillary LC system (Agilent
Technologies) coupled to an LTQ-Orbitrap XL mass spectrometer
(Thermo) operating in positive mode. Peptide mixtures were
trapped on a ReproSil-C18 reversed-phase column (Dr Maisch
GmbH; 1.5 cm  100 lm, packed in-house) at a ﬂow rate of 8 ll/
min. Peptides were separated on a ReproSil-C18 reversed-phase
column (Dr Maisch GmbH; 15 cm  50 lm, packed in-house) using
a linear gradient of 0–80% acetonitrile (in 0.1% formic acid) for
170 min at a constant ﬂow rate of 200 nl/min using a splitter.
The elution was directly sprayed into the electrospray ionization
source of the mass spectrometer. Spectra were acquired in contin-
uum mode; fragmentation of the peptides was performed in data-
dependent mode.
Raw mass spectrometry data were analyzed using the label-free
algorithm of the MaxQuant software (version 1.3.0.5) with a 3-min
time window for the match between runs option [39]. A false dis-
covery rate (FDR) of 0.01 for proteins and peptides and a minimum
peptide length of 6 amino acids were set. A site-speciﬁc FDR of 0.05
was applied separately. The Andromeda search engine [40] was
used to search the MS/MS spectra against the UniProt human data-
base (release April 2013) concatenated with the reversed versions
of all sequences. A maximum of twomissed cleavages was allowed.
The precursor mass tolerance was set to 15 ppm, the fragment
mass tolerance was set to 0.6 Da. The enzyme speciﬁcity was set
to trypsin. Cysteine carbamidomethylation-2D was set as a ﬁxed
modiﬁcation, whereas methionine oxidation and lysine ubiquitina-
tion were set as variable modiﬁcations. Before data analysis,
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tein lists.
Data analysis
The Ingenuity Pathway Analysis (IPA) software (Ingenuity Sys-
tems, www.ingenuity.com) was used to identify canonical path-
ways associated with the FK2-speciﬁc proteins identiﬁed in the
mass spectrometric analysis. Protein–protein interactions within
the FK2-speciﬁc protein group were assessed and visualized using
the GeneMANIA [41] plug-in of Cytoscape (version 2.7.0) [42]. Of
the 296 FK2-speciﬁc proteins, 6 were not recognized by the Gene-
MANIA plug-in and were therefore excluded from this analysis.
Protein interaction networks were built based on physical interac-
tions only.
Protein concentration, immunoblotting, and silver staining
Protein concentration was determined using the Thermo Scien-
tiﬁc Pierce BCA Protein Assay Kit according to the manufacturer’s
protocol.
For immunoblotting we used a rabbit polyclonal against ubiqui-
tin (Code Z0458; Dako) and a mouse monoclonal against mono-
ubiquitinated and polyubiquitinated conjugates (FK2; Enzo Life
Sciences). The anti-K48-linked polyubiquitin antibody (Apu2.07)
and the anti-K63-linked polyubiquitin antibody (Apu3.A8) were
kindly provided by Genentech and used according to their speciﬁ-
cations [43]. Alexa Fluor 680 donkey anti-rabbit, Alexa Fluor 795
donkey anti-mouse, and Alexa Fluor 795 goat anti-human (Li-Cor
Biosciences) were used to visualize the stained proteins using an
infrared imaging system (Odyssey; Li-Cor Biosciences). Immuno-
blots were quantiﬁed with the Odyssey software (version 3.0.21).
Data are expressed as integrated intensity of a speciﬁed area. The
in vitro generated K48-linked and K63-linked ubiquitin chains
were purchased from Enzo Life Sciences.
Total protein levels were visualized in-gel using a standard sil-
ver stain protocol. In short, gels were incubated for 16 h in 50%
methanol, 12% acetic acid, 0.5 ml/L 37% HCOH. Subsequently, the
gels were incubated 30 min in 50% EtOH and 1 min in 0.2 g/L Na2-
S2O3. After three 30-s washes in dH2O the gels were incubated for
45 min in 2 g/L AgNO3, 0.75 ml/L 37% HCOH. Finally the gels were
washed two times in dH2O for 30 s and incubated in 60 g/L Na2CO3,
4 mg/L Na2S2O3, 0.5 ml/L 37% HCOH until a desirable staining was
achieved.Results
Isolation of endogenously ubiquitinated protein complexes
Our goal was to develop a method for the efﬁcient isolation of
endogenously ubiquitinated protein complexes suitable for
MS-based proteomics (Fig. 1A). To this end, we compared three dif-
ferent afﬁnity-based procedures under nondenaturing conditions:
(1) agarose–TUBEs [44], a high-afﬁnity ubiquitin trap based on
UBDs that binds only polyubiquitinated conjugates; (2) UbiQap-
ture-Q matrix, a high-afﬁnity ubiquitin trap based on UBDs that
binds both monoubiquitinated and polyubiquitinated proteins;
and (3) the anti-ubiquitin antibody FK2 [45], which recognizes
both monoubiquitinated and polyubiquitinated proteins. The three
different enrichment strategies were performed in parallel using
HeLa whole-cell extracts (WCEs) in RIPA lysis buffer. As a negative
control—to determine nonspeciﬁc protein binding—random mouse
IgGs bound to protein G beads were used. The isolation of endog-
enously ubiquitinated protein complexes was assessed on an
immunoblot using a polyclonal a-ubiquitin antibody (Fig. 1B)and quantiﬁed using Odyssey software (Fig. 1C). In the negative
control, the majority of ubiquitinated proteins (89%) remained
present in the nonbound (NB) fraction and we observed virtually
no nonspeciﬁc isolation in the IP fraction. In contrast, in the three
different enrichment procedures we observed up to 80% depletion
of ubiquitinated proteins in the NB fraction, which indicates efﬁ-
cient binding of ubiquitinated proteins to the various puriﬁcation
resins. The total yield of ubiquitinated proteins isolated was high-
est in the methods using TUBEs (41%) or FK2 antibody (46%).
Since the manufacturer of the TUBEs has suggested that the
inclusion of detergents such as SDS or deoxycholate—which are
present in our RIPA lysis buffer—might have a negative impact
on the overall yield of polyubiquitinated proteins, an enrichment
experiment with the recommended TUBEs lysis buffer was per-
formed in parallel. The relative efﬁciency of ubiquitinated protein
isolation with TUBEs in TUBE buffer was comparable to those of
the TUBEs in RIPA buffer and FK2 beads isolation procedures
(Fig. 1C). However, quantiﬁcation of the WCE shows that lysis in
TUBE buffer led to an almost twofold less efﬁcient extraction of
ubiquitinated proteins from cells compared to when the cells were
lysed in RIPA buffer. TUBE isolation using the TUBE buffer was
therefore excluded from further experiments.
The efﬁciency of isolating ubiquitinated proteins was similar for
the isolation procedures using TUBEs (in RIPA buffer) and FK2 anti-
body. However, the FK2 approach resulted in a slightly higher yield
and has the further advantage of isolating monoubiquitinated pro-
teins in addition to polyubiquitinated proteins [44,45]. This was
also suggested by the stronger antibody staining for ubiquitinated
proteins observed in the low-molecular-mass region (Fig. 1b).
Therefore further experiments were performed with the FK2
antibody.
Optimization of the FK2 IP
Since DUBs and the 26S proteasome might retain some residual
activity under nondenaturing conditions, despite the presence of
speciﬁc inhibitors, a decrease in incubation time for the IP might
result in less deubiquitination and protein degradation. Fig. 2A
shows that a reduction in incubation time from 16 to 4 h did not
change the total amount of ubiquitinated proteins isolated.
Concomitantly, incubating HeLa WCE for up to 8 h at 4 C did not
decrease the total amount of ubiquitinated proteins (Supplemen-
tary Fig. 1A), indicating minimal loss of ubiquitinated proteins un-
der the conditions used.
To use the FK2 antibody more efﬁciently, we optimized the FK2/
WCE ratio by performing FK2 IPs with increasing amounts of WCE.
Proteins were allowed to bind to the FK2 beads for 4 h at 4 C.
Although the amount of unbound ubiquitinated proteins increased
when more WCE was added to the same amount of FK2 beads, the
amount of ubiquitinated proteins in the IP fractions increased as
well, up to threefold (Fig. 2A and B and Supplementary Fig. 1D).
This increase in the total amount of ubiquitinated proteins isolated
extended linearly with the increase in WCE input up to the second
highest WCE input. A maximum in the amount of recovered ubiq-
uitinated proteins was reached for the two IPs with the highest
amount of WCE input; however, at the same time the amount of
ubiquitinated proteins in the corresponding NB fraction increased
>50% for the highest amount of WCE (Fig. 2B). Together, this indi-
cated that the maximum binding capacity of the beads was
reached at the second highest amount of WCE. To exclude the pos-
sibility of a fraction of ubiquitinated proteins remaining bound to
the beads after elution, a second elution from the FK2 beads was
performed (Fig. 2A). Although additional FK2 antibody was eluted
from the beads in the second elution step for all IPs, virtually all
ubiquitinated proteins were recovered from the FK2 beads in the
ﬁrst elution step. Taken together, based on these results we
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WCE protein for every 100 ll of FK2 beads (50% slurry), which cor-
responds to 87.5 lg of FK2 antibody.
This immunoafﬁnity puriﬁcation method has been developed
for the proteomic analysis of ubiquitinated protein complexes. In
such an analysis the presence of low-abundant proteins could be
masked by large amounts of antibody in the IP fraction (as ob-
served in Fig. 2A, see the asterisks). This occurs when antibodies
are present in the sample, either during in-solution digestion or—
if proteins have the same molecular weight as the antibody—dur-
ing in-gel digestion for subsequent MS analysis. Although cross-
linking of the FK2 antibody to the protein G beads greatly de-
creased the amount of antibody in the IP fraction, it also decreased
the afﬁnity of the antibody for ubiquitinated substrates (Supple-
mentary Fig. 1B). Without cross-linking, the free antibody in the
sample cannot be separated from the ubiquitinated proteins, ren-
dering in-solution digestion unfavorable. Therefore, for future MS
experiments we chose to perform FK2 IPs without cross-linking
followed by in-gel digestion. The areas of the gel containing the
bands corresponding to antibody chains were excised into separate
gel slices to minimize the presence of antibody in the other gel
slices.
Since only a limited volume can be loaded into a slot of an SDS–
PAGE gel lane, the volume into which bound proteins are eluted
from the beads is limited as well when 2 Laemmli buffer is used.
For large-scale IP experiments, elution from the beads followed by
a protein concentration step is therefore necessary. The compati-bility of three different elution strategies with a subsequent con-
centration step using centrifugal ﬁlters (Amicon Ultra, Millipore)
was investigated by releasing ubiquitinated protein complexes
from the FK2 beads into (1) 8 M urea buffer, (2) 2% SDS, or (3)
0.1 M glycine, pH 2 (Fig. 2C and Supplementary Fig. 1E). After elu-
tion the beads were boiled in 2 Laemmli buffer to assess residual
bound proteins for elution efﬁciency. Fig. 2C shows that elution
with 2% SDS was the most efﬁcient: not only was the majority
(77%) of bound ubiquitinated proteins eluted within the ﬁrst two
rounds of elution, but also almost no residual proteins (3%) re-
mained bound to the FK2 beads after four elution rounds, as illus-
trated by the absence of ubiquitinated protein signal in the LB lane
(Fig. 2C and Supplementary Fig. 1C).
Characterization of the FK2 IP
The FK2 antibody is a mouse monoclonal recognizing both
monoubiquitinated and polyubiquitinated conjugates. According
to the manufacturer’s data sheet the FK2 antibody can recognize
various types of ubiquitin chains; however, it is unknown if it
has equal afﬁnities for all seven ubiquitin chain linkages and for
different protein substrates. If the FK2 antibody does have such a
bias, then a speciﬁc fraction of ubiquitinated proteins will not be
immunodepleted. To investigate this, we compared by immuno-
blot analysis the FK2 antibody with a polyclonal antibody that rec-
ognizes both monoubiquitinated and polyubiquitinated conjugates
as well as free ubiquitin [46]. Samples of small-scale FK2 IPs with
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PAGE and immunoblotted with FK2 and the polyclonal a-ubiquitin
antibody. The staining patterns for the IP samples were similar for
both antibodies: we observed a strong depletion of ubiquitinated
proteins in the NB fraction and a speciﬁc enrichment in the FK2
IP fraction (Fig. 3A and B). The relative signal intensities in the IP
fractions were also similar for both antibodies (Fig. 3E), suggesting
that FK2 has no bias for binding speciﬁc types of ubiquitin chain
linkages or protein substrates. To further support the notion that
proteins with all-ubiquitin chain linkages may be isolated using
the FK2 antibody, the immunoblots were also stained with two
available chain-speciﬁc antibodies that speciﬁcally recognize
K48-linked and K63-linked ubiquitin chains. The chain speciﬁcityof the antibodies was conﬁrmed by also loading K48-linked and
K63-linked ubiquitin chains that were generated in vitro onto the
gels. The staining patterns and relative signal intensities of ubiqui-
tinated proteins in the IP fractions were again very similar for the
antibodies used (Fig. 3A–E).
Proteolytic digestion of ubiquitinated proteins with trypsin
generates a speciﬁc diglycine (Gly–Gly) remnant on the ubiquiti-
nated lysine. This remnant causes a distinct mass shift on the pep-
tide mass that can be used to precisely identify and localize
ubiquitination sites by MS. We performed in-gel digestion on an
FK2 IP fraction with trypsin and identiﬁed ubiquitin-modiﬁed pep-
tides on positions K6, K11, K27, K29, K48, and K63 of ubiquitin,
representing six of the seven possible chain linkages of ubiquitin
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(B) polyclonal a-ubiquitin, (C) a-K48-linked polyubiquitin (Apu2.07), and (D) a-K63-linked polyubiquitin (Apu3.A8). As speciﬁcity control for the chain-linkage-speciﬁc
antibodies, in vitro generated K48 and K63 ubiquitin chains (4 lg) were loaded. The last three lanes of the immunoblot in (C) were scanned at a higher intensity. M, molecular
weight marker; WCE, whole-cell extract; NB, nonbound fraction; IP, immunoprecipitated proteins. (E) Odyssey quantiﬁcation of (A–D). Recovery efﬁciency was determined
by normalization to the total of ubiquitinated proteins as shown by the WCE. (F) Endogenously ubiquitinated protein complexes were isolated from HeLa WCE in two
independent experiments. FK2 beads and control beads were washed 4 with either PBS or RIPA buffer before elution of bound proteins in 2 Laemmli buffer. The
immunoblot was stained with FK2 and a polyclonal a-ubiquitin antibody. Total proteins levels were assessed with silver staining, WCE and NB were diluted 200 compared
to the IP fractions. Wash, ﬁnal wash fraction before protein elution. (G) Odyssey quantiﬁcation of (F). Recovery efﬁciency was determined by normalization to the total of
ubiquitinated proteins as shown by the WCE.
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this suggests that there is no bias for FK2 in binding speciﬁc types
of ubiquitin chains or protein substrates under the conditions used.
To further evaluate the application of the FK2 antibody for our
immunoafﬁnity puriﬁcation method (intended for the proteomic
analysis of ubiquitinated protein complexes), we performed two
additional independent FK2 IP experiments with random IgG beads
as a negative control for MS analysis. This replicate experiment dif-
fered only in the ﬁnal washing step: beads were washed with
either PBS or RIPA buffer four times. We observed a strong, speciﬁc,
and reproducible enrichment for ubiquitinated proteins, as shown
by immunoblot analysis using two different antibodies (Fig. 3F).
Additionally, analysis of total protein levels—as visualized in-gel
by silver staining—showed an enormous decrease (>200-fold) in
total amount of protein in the IP fraction (Fig. 3F), while most of
the total ubiquitinated protein signal (Fig. 3G) was recovered as
shown by the immunoblot analysis. These results illustrate a high
degree of speciﬁc enrichment for ubiquitinated factors.
MS analysis
To further conﬁrm the speciﬁcity and reproducibility of our
enrichment strategy, the IP fractions of the two independently exe-
cuted FK2 IPs (Fig. 3F) were in-gel digested and run on an LTQ-
Orbitrap XL mass spectrometer. Raw mass spectrometry data were
analyzed using the label-free quantitation (LFQ) algorithm of the
MaxQuant software (version 1.3.0.5).
The proteins identiﬁed were considered true FK2 antibody
interactors when an LFQ intensity (the total signal intensities of
the peptides identifying each protein) was listed in the FK2 IP
and there was either no LFQ intensity observed in the control IP
or the FK2/control LFQ intensity ratio was >2. Of the identiﬁed
and validated 951 true interactors, 296 proteins were identiﬁed
in both experiments (Fig. 4A and Supplementary Table 2A).
To conﬁrm that the presented enrichment method indeed iso-
lates ubiquitinated and ubiquitination-related proteins, we per-
formed three further analyses. First, we performed a functional
pathway analysis of the 296 FK2-speciﬁc proteins found in both
experiments. The IPA software (Ingenuity Systems, www.ingenu-
ity.com) identiﬁed 32 canonical pathways (p < 0.05, Fisher’s exact
test; Supplementary Table 3) with the protein ubiquitination path-
way as most signiﬁcantly present (Fig. 4B), indicating an enrich-
ment for ubiquitinated and ubiquitination-related proteins. As
expected, a wide variety of other pathways was also identiﬁed,
indicative of the importance of ubiquitination in different path-
ways. In line with this, when the 296 FK2-speciﬁc proteins were
subjected to a Gene Ontology (GO) enrichment analysis using the
functional annotation tool DAVID [47], proteins associated with
ubiquitination in the Biological Processes term were highly en-
riched for (Fig. 4C and Supplementary Table 4). Finally, the FK2-
speciﬁc protein list was compared with two large datasets of ubiq-
uitinated proteins that were recently identiﬁed in peptide screens
using antibodies recognizing the speciﬁc diglycine remnant on the
ubiquitinated lysine [32,33]. There was a 62% overlap with the
dataset of Kim et al. [32] and a 70% overlap with that of Wagner
et al. [33], indicating that a high percentage of the isolated proteins
were indeed ubiquitinated (Supplementary Table 2B).
One of the advantages of our approach is that ubiquitinated
protein complexes can be isolated. To demonstrate that many of
the proteins present in the FK2 IP fraction are part of protein com-
plexes we evaluated their protein–protein interactions. Functional
association data were obtained and visualized using the GeneMA-
NIA plug-in in Cytoscape. The resulting protein network showed
that 53% of the FK2-speciﬁc proteins interacted with at least one
other protein within the FK2-speciﬁc protein group (Fig. 4D). In
contrast, when four sets of 290 proteins were randomly chosenfrom the Ensembl database, a signiﬁcantly smaller percentage of
proteins interacted (on average 15%, p = 3.3  1023, Fisher’s exact
test; Fig. 4D). Since a low percentage of interacting proteins in ran-
dom protein sets could be explained by low-abundant, tissue-spe-
ciﬁc, and/or badly annotated proteins, we also determined the
percentage of interacting proteins in four random sets of proteins
that were extracted from the two large datasets of ubiquitinated
proteins recently identiﬁed in peptide screens by Kim et al. [32]
and Wagner et al. [33]. Because the enrichment step in both of
these screens was performed at the peptide level—after a denatur-
ing and digestion step—protein complexes were not isolated and
all information about protein–protein associations was lost. For
the random sets extracted from Kim et al. [32] and from Wagner
et al. [33], the percentages of interacting proteins were on average
25% and 29%, respectively (Supplementary Fig. 2). Although these
percentages were higher than those found for the random sets col-
lected from the Ensembl database, the percentages of interacting
proteins for both datasets were similar and signiﬁcantly lower than
the 53% interacting proteins in the FK2-speciﬁc protein dataset
(p = 1.8  1012 for the Kim et al. dataset and 1.4  109 for the
Wagner et al. dataset, Fisher’s exact test). This clearly indicates that
the optimized enrichment method described here indeed isolates
endogenously ubiquitinated protein complexes.Discussion
We present here an immunoafﬁnity puriﬁcation method for the
proteomic analysis of endogenously ubiquitinated protein com-
plexes. Proteins were successfully isolated using the FK2 antibody
bound to protein G-beaded agarose, which recognizes monoubiq-
uitinated and polyubiquitinated conjugates (Figs. 1 and 3F). An
optimal WCE/FK2 ratio was determined for the efﬁcient isolation
of ubiquitinated proteins and an IP incubation time of 4 h was
shown to be sufﬁcient for immunodepletion of ubiquitinated pro-
teins from WCE of human cells (Fig. 2A). A high degree of speciﬁc
enrichment for ubiquitinated factors was achieved, as shown by
the high recovery of ubiquitinated proteins (up to 86%, Fig. 3G),
while the total amount of proteins decreased strongly in the IP
fraction (>200-fold, as assessed on a silver-stained gel in Fig. 3F).
Finally, the efﬁcient elution of bound proteins with 2% SDS from
the FK2 beads (Fig. 2C) illustrates the compatibility of this method
with large-scale proteomic assays.
The MS analysis of two small-scale FK2 IPs resulted in the iden-
tiﬁcation of 296 FK2-speciﬁc proteins in both experiments
(Fig. 4A). The isolation of ubiquitinated proteins and ubiquitina-
tion-related proteins was conﬁrmed by pathway analyses using
IPA and GO-annotation enrichment (Fig. 4B and C). Additionally,
comparing the FK2-speciﬁc proteins with databases of ubiquitinat-
ed proteins in the literature indicated that a high percentage of
proteins in the enriched fraction in our assay was indeed ubiquiti-
nated (Supplementary Table 2B).
Further characterization of the FK2 IP, with immunoblot analy-
sis using chain-linkage-speciﬁc antibodies and two different a-
ubiquitin antibodies, suggested that there was no detectable bias
for the FK2 antibody in binding speciﬁc types of ubiquitin chains
or protein substrates under the conditions used (Fig. 3A–D). This
was further supported by MS analysis of FK2-enriched proteins,
which identiﬁed six (of seven possible) speciﬁc polyubiquitin chain
linkages. The fact that the K33 ubiquitin-modiﬁed peptide was not
identiﬁed could be explained by the fact that it is the least abun-
dant chain-linkage type in unperturbed cells [22] and that these
experiments were performed on a small scale (IPs were performed
on WCE from a single 9-cm dish).
The FK2 IP was performed under nondenaturing conditions,
which allows the preservation of protein complexes. Most biolog-
D
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GO:0051437 positive regulation of ubiquitin-protein ligase activity
during mitotic cell cycle
24.3 1.2E-28
GO:0051444 negative regulation of ubiquitin-protein ligase activity 23.8 3.1E-27
GO:0051352 negative regulation of ligase activity 23.8 3.1E-27
GO:0031145 anaphase-promoting complex-dependent proteasomal
ubiquitin-dependent protein catabolic process
23.6 4.8E-26
GO:0051436 negative regulation of ubiquitin-protein ligase activity
during mitotic cell cycle
23.6 4.8E-26
GO:0051351 positive regulation of ligase activity 23.4 3.2E-29
GO:0051439 regulation of ubiquitin-protein ligase activity during
mitotic cell cycle
23.2 5.1E-28
GO:0051438 regulation of ubiquitin-protein ligase activity 22.6 8.6E-30
GO:0051340 regulation of ligase activity 21.8 3.3E-29
C
B
Pr
ot
ei
n 
U
bi
qu
iti
na
tio
n 
Pa
th
w
ay
H
yp
ox
ia
 S
ig
na
lin
g 
in
 th
e 
C
ar
di
ov
as
cu
la
r S
ys
te
m
EI
F2
 S
ig
na
lin
g
m
TO
R
 S
ig
na
lin
g
An
tig
en
 P
re
se
nt
at
io
n 
Pa
th
w
ay
0
5
10
15
20
25
30
-lo
g(
p-
va
lu
e)
A
406 296 249PBS RIPA
Threshold
Fig.4. Mass spectrometric data analysis. (A) Venn diagram of the FK2-speciﬁc MS-identiﬁed proteins in two independently executed FK2 IPs. (B) Functional annotation of the
FK2-speciﬁc proteins identiﬁed in both experiments into canonical pathways using IPA. The ﬁve most signiﬁcant pathways are shown. The signiﬁcance of the pathways was
determined using Fisher’s exact test. (C) GO annotation enrichment analysis using DAVID. The 10 most enriched biological processes with p < 0.005 are shown. The p values
were corrected for multiple hypotheses testing using Bonferroni FDR. (D) Protein interaction networks were built using association data based on physical interactions, which
were obtained through the GeneMANIA database and visualized using Cytoscape. Every dot represents a protein and connecting lines represent a physical interaction.
Percentages of interacting proteins for the random protein sets are averages of n = 5. For the random protein set from the Ensembl database a representative protein
interaction network is shown.
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however, within complexes not all interactors are necessarily ubiq-
uitin modiﬁed. Evaluation of protein–protein interactions within
the FK2-speciﬁc protein group showed that a signiﬁcantly higherpercentage (53%) of the FK2-speciﬁc proteins are interacting
among one another compared to proteins in random datasets from
the Ensembl database (15%) or datasets of ubiquitinated-peptide
IPs from Kim et al. (25% [32]) and Wagner et al. (29% [33])
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tein complexes are indeed isolated. MS analysis identiﬁed 296 FK2-
speciﬁc proteins in two FK2 IPs using PBS or RIPA buffer as the ﬁnal
wash buffer. Additionally, 655 proteins were found in only one of
these IPs. Interestingly, 62% of the additional identiﬁed proteins
were speciﬁc for the PBS-washed IP (Fig. 4A and Supplementary
Table 2A). Since PBS is a much milder buffer than RIPA buffer in
terms of salt and detergent concentrations, our data suggest that
changing the wash buffer stringency can result in a different
amount of proteins isolated. It will be of interest to study whether
changes in wash buffer stringency will result in the identiﬁcation
of additional ubiquitinated proteins or proteins that are transiently
or weakly bound to ubiquitinated protein complexes.
We showed that the FK2 IP efﬁciently enriched for ubiquitinat-
ed proteins of different chain linkages; however, we cannot be cer-
tain that all ubiquitinated factors were equally efﬁcient isolated.
For this reason we performed an isolation of endogenously ubiqui-
tinated protein complexes using the UbiQapture-Q matrix under
the same conditions as for the FK2 IP. MS analysis identiﬁed a total
of 735 UbiQapture-Q-speciﬁc proteins (Supplementary Table 2A).
From this set 351 overlapped with the FK2-speciﬁc proteins (Sup-
plementary Fig. 2B). This indicates that while these methods iso-
late identical proteins, a considerable amount of additional
method-speciﬁc proteins was also isolated. This suggests that the
FK2 isolation method can be combined with other isolation proce-
dures for ubiquitinated proteins, to broaden the pool of proteins
isolated and to overcome a putative bias in the isolation procedure.
A limitation of the FK2 isolation method presented here is that,
apart from sites on ubiquitin itself, we identiﬁed only a few ubiq-
uitination sites on substrate proteins (Supplementary Table 1). It is
therefore not possible to differentiate with certainty between
ubiquitinated and nonubiquitinated proteins based on the results
of the MS analysis alone. The low number of ubiquitination sites
identiﬁed could be explained by the absence of an enrichment pro-
tocol for ubiquitinated peptides in our assay. The presence of ubiq-
uitinated peptides is probably masked by large amounts of
nonubiquitinated peptides from the same protein and from non-
ubiquitinated interactors of the ubiquitinated proteins. Enrich-
ment strategies for the detection of ubiquitination sites are
available and would be an ideal tool to complement the data gen-
erated with this FK2-enrichment strategy. The recently developed
method for the immunoenrichment of ubiquitinated peptides
using a diglycine-speciﬁc antibody [31–35] is highly efﬁcient and
could be implemented to discriminate between ubiquitinated pro-
teins and interacting nonubiquitinated proteins in our FK2 samples
containing ubiquitinated protein complexes.
In conclusion, the use of the FK2 antibody for protein isolation
enables the enrichment of endogenously ubiquitinated proteins.
The advantage of this method is that possible negative side effects
of introducing tagged ubiquitin into the cells—such as a biased
incorporation into monoubiquitination or certain ubiquitin chains
and/or interference with, e.g., the stability, activity, and localiza-
tion of protein substrates—are therefore prevented. Additionally,
the FK2 isolation method described here is broadly applicable as
it can also be used to isolate proteins from tissues and cell types
that are usually difﬁcult to transfect.
In recent years, mass spectrometry has become the method of
choice for studying the proteome and, more speciﬁcally, PTMs. It
can be used not only to analyze proteins and protein complexes,
but also to dissect biological pathways and identify proteins not
previously known to be involved in speciﬁc processes. Moreover,
various quantitative mass spectrometry strategies are available
for detecting and quantifying the effects of a speciﬁc stimulus in
a proteome-wide fashion [48]. Label-based quantiﬁcation meth-
ods—such as stable isotope labeling by amino acids in cell culture
(SILAC) and isobaric tags for relative and absolute quantitation[48]—are very suitable for comparing the abundance of proteins
on a proteome-wide scale since they can provide a quantitative ra-
tio for a large number of proteins. Combining the method we de-
scribe for the isolation of endogenously ubiquitinated protein
complexes using the FK2 IP with such quantitative proteomic tech-
niques would therefore generate a powerful tool to study dynamic
changes in the ubiquitinome following, for example, environmen-
tal stresses, drug treatment, or knockdown of proteins or when
comparing two disease states.
Recently we showed a clear example of the successful applica-
tion of this approach [49]. Combining the FK2 IP described here
with SILAC-based proteomics identiﬁed several differentially ubiq-
uitinated proteins in HeLa cells following UV irradiation. The most
prominent factors were DNA repair proteins that are involved in
nucleotide excision repair (NER) and that are known to be ubiqui-
tinated. Importantly, it also resulted in the identiﬁcation of UVSSA
(UV-stimulated scaffold protein A) as the causative gene for
UV-sensitive syndrome, a previously unresolved NER deﬁciency
disorder [49–51]. Follow-up experiments showed that the ubiqui-
tination status of UVSSA remained unchanged after UV and that
this protein was copuriﬁed as part of a UV-induced ubiquitinated
protein complex [49]. These data illustrate the value and advan-
tage of our nondenaturing immunoafﬁnity puriﬁcation method,
which is capable of isolating both ubiquitinated proteins and their
interacting proteins, for the proteomic analysis of endogenously
ubiquitinated protein complexes.Acknowledgments
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